Asundexian versus Apixaban in Patients with Atrial Fibrillation

Original Article

J.P. Piccini, M.R. Patel, J. Steffel, K. Ferdinand, I.C.V. Gelder, A.M. Russo, C.-S. Ma, S.G. Goodman, J. Oldgren, C. Hammett, R.D. Lopes, M. Akao, R.D. Caterina, P. Kirchhof, D.A. Gorog, M. Hemels, M. Rienstra, W.S. Jones, J. Harrington, G.Y. Lip, S.J. Ellis, F.W. Rockhold, C. Neumann, J.H. Alexander, T. Viethen, J. Hung, R. Coppolecchia, H. Mundl, and V. Caso

N Engl J Med 2025;392:23-32

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
01/01/2025
Course expires: 
01/02/2027

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Please sign in or create an account to take the course.